Suppr超能文献

植物乳杆菌CGMCC9513通过调节肠道微生物群和激活芳烃受体协同增强肠道屏障来缓解结肠炎的作用

The Role of Lactiplantibacillus plantarum CGMCC9513 in Alleviating Colitis by Synergistic Enhancement of the Intestinal Barrier Through Modulating Gut Microbiota and Activating the Aryl Hydrocarbon Receptor.

作者信息

Lu Hongyu, Zhang Guoqing, Wang Kaidi, Liu Kefei, Gao Yingrui, Chen Jinyan, Li Yixiang, Yan Jianhua

机构信息

Medical School of Guangxi University, Nanning, 530004, China.

Tianjin Shengji Group., Co., Ltd, Huayuan Industrial Zone, No. 2, Hai Tai Development 2 Road, Tianjin, 300384, China.

出版信息

Probiotics Antimicrob Proteins. 2025 Apr 29. doi: 10.1007/s12602-025-10551-0.

Abstract

Ulcerative colitis (UC) has become a global health issue. This study evaluated whether administering Lactiplantibacillus plantarum CGMCC9513 to dextran sulfate sodium (DSS)-induced colitis mice could alleviate colitis by modulating gut microbiota imbalance and activating the aryl hydrocarbon receptor (AhR) to enhance intestinal barrier function. The anti-inflammatory effect and AhR activation ability of L. plantarum CGMCC9513 were evaluated with lipopolysaccharide (LPS)-induced cell inflammation model; 25 male BALB/c mice were divided into blank group (CNG), model group (DSS), L. plantarum CGMCC9513-treated group (LPDT), and L. plantarum CGMCC9513 control group (LP). The mice were pre-administered L. plantarum CGMCC9513 for 14 days and continued to receive it during DSS induction. Symptoms during induction, goblet cell count, expression of MUC2 and Occludin proteins, and changes in gut microbiota were observed. Subsequently, the expression of cytokines interleukin-10 (IL-10), tumor necrosis factor (TNF-α), interleukin-1β (IL-1β) and AhR activation status was determined. The study found that L. plantarum CGMCC9513 could alleviate cell inflammation induced by LPS and activate AhR in vitro. For colitis mice, it could reduce colonic mucosal damage and enhance intestinal barrier function. Regarding gut microbiota changes, L. plantarum CGMCC9513 mainly downregulated Bacteroides, Blautia, Escherichia-Shigella, and Lachnospiraceae_ NK4A136_group and upregulated Firmicutes, Lactobacillus. It reduces the risk of bacterial translocation and increases beneficial gut bacteria. L. plantarum CGMCC9513 reduced the expression of pro-inflammatory cytokines TNF-α and IL-1β while increasing the expression of anti-inflammatory cytokine IL-10. Meanwhile, increased expression of AhR and Cytochrome P450 1A1 (CYP1A1) proteins indicated AhR activation by L. plantarum CGMCC9513. In conclusion, L. plantarum CGMCC9513 can synergistically enhance intestinal barrier alleviation in colitis mice by modulating gut microbiota imbalance and activating AhR.

摘要

溃疡性结肠炎(UC)已成为一个全球性的健康问题。本研究评估了给葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠施用植物乳杆菌CGMCC9513是否可以通过调节肠道微生物群失衡和激活芳烃受体(AhR)以增强肠道屏障功能来减轻结肠炎。用脂多糖(LPS)诱导的细胞炎症模型评估植物乳杆菌CGMCC9513的抗炎作用和AhR激活能力;将25只雄性BALB/c小鼠分为空白组(CNG)、模型组(DSS)、植物乳杆菌CGMCC9513治疗组(LPDT)和植物乳杆菌CGMCC9513对照组(LP)。小鼠预先施用植物乳杆菌CGMCC9513 14天,并在DSS诱导期间继续接受该处理。观察诱导期间的症状、杯状细胞计数、MUC2和闭合蛋白的表达以及肠道微生物群的变化。随后,测定细胞因子白细胞介素-10(IL-10)、肿瘤坏死因子(TNF-α)、白细胞介素-1β(IL-1β)的表达和AhR激活状态。研究发现,植物乳杆菌CGMCC9513可以减轻LPS诱导的细胞炎症并在体外激活AhR。对于结肠炎小鼠,它可以减少结肠黏膜损伤并增强肠道屏障功能。关于肠道微生物群的变化,植物乳杆菌CGMCC9513主要下调拟杆菌属、布劳特氏菌属、埃希氏菌-志贺氏菌属和毛螺菌科_NK4A136_组,并上调厚壁菌门、乳杆菌属。它降低了细菌易位的风险并增加了有益的肠道细菌。植物乳杆菌CGMCC9513降低了促炎细胞因子TNF-α和IL-1β的表达,同时增加了抗炎细胞因子IL-10的表达。同时,AhR和细胞色素P450 1A1(CYP1A1)蛋白表达的增加表明植物乳杆菌CGMCC9513激活了AhR。总之,植物乳杆菌CGMCC9513可以通过调节肠道微生物群失衡和激活AhR协同增强结肠炎小鼠的肠道屏障缓解作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验